Invention Grant
- Patent Title: Therapeutic oligonucleotides
-
Application No.: US15738564Application Date: 2016-06-29
-
Publication No.: US10590425B2Publication Date: 2020-03-17
- Inventor: Heather O'Neill , Mark Miglarese , David Spetzler
- Applicant: Caris Science, Inc.
- Applicant Address: US TX Irving
- Assignee: Caris Science, Inc.
- Current Assignee: Caris Science, Inc.
- Current Assignee Address: US TX Irving
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2016/040157 WO 20160629
- International Announcement: WO2017/004243 WO 20170105
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/115 ; A61K31/711 ; A61K47/68 ; G01N33/53

Abstract:
Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a therapeutic target such as Complement Component 1, Q Subcomponent (C1q) or a subunit thereof.
Public/Granted literature
- US20180171337A1 THERAPEUTIC OLIGONUCLEOTIDES Public/Granted day:2018-06-21
Information query
IPC分类: